Many patients find the investment worthwhile given the rapid symptom improvement and reliable results compared to oral options that may not deliver equivalent benefits
We offer injections in multiple forms because not everyone metabolizes B12 the same way, and the form actually matters more than most patients realize
I worried that I was on track to develop an even more serious condition
Tesamorelin has the strongest evidence specifically for reducing visceral adipose tissue
That kind of deep, never-ending fatigue
In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo